Bill Title: Urges the Congress of the United States to help ensure that any new legislation allowing for approval of biosimilar drugs includes provisions to ensure that the public health is protected by adequate testing of biosimilar products and physician control over which treatments their patients receive, and that the legislation preserves the ability to create innovative and important new biotechnology therapies.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2009-12-01 - Rule 19(b) / Re-referred to Rules Committee [HJR0035 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	Not Avail	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for Illinois HJR0035

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for Illinois HJR0035 currently on file.

Social Comments on IL HJR0035